E
Applied Therapeutics, Inc.
APLT
$0.4601
-$0.0288-5.89%
E
Sell
1/23/2025Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 1/23/2025 due to a decline in the total return index and volatility index.
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 1/23/2025 due to a decline in the total return index and volatility index.
D
Sell
12/12/2024Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 12/12/2024 due to an increase in the valuation index.
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 12/12/2024 due to an increase in the valuation index.
E
Sell
11/8/2024Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 11/8/2024 due to a substantial decline in the growth index and valuation index. Earnings per share declined from -$0.1302 to -$0.4752, EBIT declined 45.51% from -$20.44M to -$29.74M, and total revenue declined 15.28% from $144 to $122.
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 11/8/2024 due to a substantial decline in the growth index and valuation index. Earnings per share declined from -$0.1302 to -$0.4752, EBIT declined 45.51% from -$20.44M to -$29.74M, and total revenue declined 15.28% from $144 to $122.
D
Sell
7/10/2023Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 7/10/2023 due to an increase in the valuation index, total return index and volatility index.
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 7/10/2023 due to an increase in the valuation index, total return index and volatility index.
E
Sell
3/14/2023Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and valuation index.
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and valuation index.
E
Sell
2/8/2023Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.11 to 0.21, and the quick ratio declined from 1.32 to 1.02.
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.11 to 0.21, and the quick ratio declined from 1.32 to 1.02.
D
Sell
8/9/2022Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 8/9/2022 due to a decline in the volatility index and total return index.
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 8/9/2022 due to a decline in the volatility index and total return index.
D
Sell
7/20/2022Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 7/20/2022 due to an increase in the volatility index.
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 7/20/2022 due to an increase in the volatility index.
D
Sell
7/5/2022Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 7/5/2022 due to a decline in the volatility index.
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 7/5/2022 due to a decline in the volatility index.
D
Sell
5/16/2022Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 5/16/2022 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$1.0456 to -$0.882, EBIT increased 14.8% from -$27.11M to -$23.1M, and operating cash flow increased 9.4% from -$26.94M to -$24.41M.
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 5/16/2022 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$1.0456 to -$0.882, EBIT increased 14.8% from -$27.11M to -$23.1M, and operating cash flow increased 9.4% from -$26.94M to -$24.41M.
D
Sell
5/5/2022Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
Applied Therapeutics, Inc. (APLT) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, volatility index and valuation index.
Applied Therapeutics, Inc. (APLT) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, volatility index and valuation index.
D
Sell
3/15/2022Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 3/15/2022 due to a major decline in the total return index, volatility index and growth index. Operating cash flow declined 71.99% from -$15.67M to -$26.94M.
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 3/15/2022 due to a major decline in the total return index, volatility index and growth index. Operating cash flow declined 71.99% from -$15.67M to -$26.94M.
D
Sell
11/15/2021Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 11/15/2021 due to an increase in the growth index. Operating cash flow increased 39.54% from -$25.91M to -$15.67M.
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 11/15/2021 due to an increase in the growth index. Operating cash flow increased 39.54% from -$25.91M to -$15.67M.
D
Sell
11/8/2021Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the volatility index and total return index.
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the volatility index and total return index.
D
Sell
8/13/2020Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to D from D+ on 8/13/2020 due to a major decline in the growth index, solvency index and valuation index. EBIT declined 126.84% from -$12.47M to -$28.28M, earnings per share declined from -$0.5935 to -$1.2718, and the quick ratio declined from 18.24 to 7.34.
Applied Therapeutics, Inc. (APLT) was downgraded to D from D+ on 8/13/2020 due to a major decline in the growth index, solvency index and valuation index. EBIT declined 126.84% from -$12.47M to -$28.28M, earnings per share declined from -$0.5935 to -$1.2718, and the quick ratio declined from 18.24 to 7.34.
D
Sell
8/3/2020Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D+ from D on 8/3/2020 due to a major increase in the growth index, valuation index and solvency index. The quick ratio increased from 2.76 to 18.24, debt to equity declined from 0.01 to 0, and earnings per share increased from -$1.9445 to -$0.5935.
Applied Therapeutics, Inc. (APLT) was upgraded to D+ from D on 8/3/2020 due to a major increase in the growth index, valuation index and solvency index. The quick ratio increased from 2.76 to 18.24, debt to equity declined from 0.01 to 0, and earnings per share increased from -$1.9445 to -$0.5935.
D
Sell
5/1/2020Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index and valuation index.
Applied Therapeutics, Inc. (APLT) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index and valuation index.
D
Sell
3/11/2020Downgrade
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 3/11/2020 due to a noticeable decline in the volatility index.
Applied Therapeutics, Inc. (APLT) was downgraded to D- from D on 3/11/2020 due to a noticeable decline in the volatility index.
D
Sell
1/27/2020Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to D from E+ on 1/27/2020 due to an increase in the total return index and efficiency index.
Applied Therapeutics, Inc. (APLT) was upgraded to D from E+ on 1/27/2020 due to an increase in the total return index and efficiency index.
E
Sell
11/5/2019Upgraded
Applied Therapeutics, Inc. (APLT) was upgraded to E+ from E on 11/5/2019 due to a noticeable increase in the total return index and volatility index.
Applied Therapeutics, Inc. (APLT) was upgraded to E+ from E on 11/5/2019 due to a noticeable increase in the total return index and volatility index.
E
Sell
8/19/2019None
Applied Therapeutics, Inc. (APLT) was downgraded to E from U on 08/19/2019.
Applied Therapeutics, Inc. (APLT) was downgraded to E from U on 08/19/2019.
NASDAQ
04/01/2025 4:00PM Eastern
Quotes delayed
